MillionMilesAway
Well-Known Member
In the UK, the AstraZeneca vaccine was submitted on Dec 23 and given approval on Dec 30. The J&J vaccine is a similar type but will presumably only have data for the single-dose; assuming it meets their requirements, I suspect that both the UK and the US will approve this one comparatively quickly.
However, if there aren't sufficient stocks to meet needs, it might be prudent to delay announcing its approval to the public and instead wait a week or so until stocks are set to roll.
ok, hadn't realised AZ was that fast - I thought it was much longer.